Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
111-77-3
Name of the chemical
2-(2-methoxyethoxy)-ethanol
Concentration
N/A
EC/CAS
112-34-5
Name of the chemical
2-(2-butoxyethoxy)ethanol
Concentration
N/A
General Information
Revision date
2020-11-06
Product name
PITT-TECH DTM Primer Finish White
supplier name
PPG Canada Inc
Emergency telephone
(412) 434-4515 (U.S.
Icons in SDS
Company Information
company name
PPG Canada Inc
GHS Information
Signal word
Warning
Section 2
2.1 Classification of the substance or mixture
CARCINOGENICITY - Category 2 TOXIC TO REPRODUCTION - Category 2 This product contains TiO2 which has been classified as a GHS Carcinogen Category 2 based on its IARC 2B classification. For many PPG products, TiO2 is utilized as a raw material in a liquid coating formulation. In this case, the TiO2 particles are bound in a matrix with no meaningful potential for human exposure to unbound particles of TiO2 when the product is applied with a brush or roller. Sanding the coating surface or mist from spray applications may be harmful depending on the duration and level of exposure and require the use of appropriate personal protective equipment and/or engineering controls (see Section 8).
Signal word
Warning
Hazard statements
Suspected of causing cancer. Suspected of damaging fertility or the unborn child.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection.
Response
IF exposed or concerned: Get medical advice or attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Sanding and grinding dusts may be harmful if inhaled. Emits toxic fumes when elements heated.
Ingredient(s) with unknown acute toxicity
23% (oral), 33.1% (dermal), 29.3% (inhalation)